Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Analysis of Neuromuscular Disease

NCT00272883 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT00272883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00272883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Analysis of Neuromuscular Disease
Lead sponsor
Boston Children's Hospital
Phase
Observational
Overall status
Recruiting
Start date
August 31, 2003
Completion date
January 31, 2050
Enrollment
4,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central core disease, centronuclear myopathy, congenital fiber type disproportion, multiminicore disease, myotubular myopathy, nemaline myopathy, rigid spine muscular dystrophy, undefined congenital myopathy